Earnings per share for the last twelve months: Arcadia Biosciences Inc (RKDA)

Public company logo of Arcadia Biosciences Inc (RKDA)

Arcadia Biosciences (RKDA) relies on the patent protection of its hemp and wheat varieties to compete against industry behemoths. Management aims to capitalize on the implementation of beneficial crops. A strategic shift toward the commercialization of branded health food products mitigates the risks associated with GMO developments. Net income per share over the last 12 months (TTM) illustrates financial stability, where the mark -4.91 characterizes this parameter.

RKDA (Arcadia Biosciences) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/16/2026

Analytical breakdowns for Arcadia Biosciences (RKDA)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Summary company analytics:Arcadia Biosciences Corp (RKDA)
Flagship merchandise of Arcadia Biosciences Corp

Arcadia Biosciences (RKDA) innovation development in functional nutrition is reflected in the rolling trailing twelve-month earnings per share trend. This metric demonstrates real business efficiency by excluding short-term market volatility. The calculation is based on dividing the total net income over 12 months by the total number of outstanding shares. For the creators of GoodWheat, this indicator confirms the ability to monetize unique wheat varieties. It is critical for investors to track this trend for an objective assessment of the company's capitalization.